0
Want this question answered?
Be notified when an answer is posted
Add your answer:
Earn +20 pts
What does the medical abbreviation NYHA Class 2 mean?
The medical abbreviation "NYHA Class 2" refers to the New York Heart Association Functional Classification, which categorizes heart failure patients based on symptom severity. Class 2 indicates that the patient experiences mild symptoms with ordinary physical activity, such as fatigue or shortness of breath.
Does the medical term for a heart attack have letters in it like ny30?
No, but there's a NYHA classification system for CHF; perhaps that's what you're thinking of.
What is etoricoxib tabs 90mg used for?
Etoricoxib tab Trade name Arcoxia Drug class Cycloxygenase-2 (COX-2) inhibitor Presentation 60mg: Dark green apple-shape biconvex film coated tablets debossed ARCOXIA 60 on one side and 200 on the other side. 90mg: White apple-shape biconvex film coated tablets debossed ARCOXIA 90 on one side and 202 on the other side. 120mg: Pale green apple-shape biconvex film coated tablets debossed ARCOXIA 120 on one side and 204 on the other side. Cost 60mg: RM3.20/tab; 90mg: RM3.20/tab; 120mg: RM5.20/tab. Prescriber Orthopaedics, Pain management team Indication Acute and chronic treatment of osteoarthritis (OA) & rheumatoid arthritis (RA). Treatment of acute gouty arthritis, acute pain, including that related to primary dysmenorrhea and minor dental procedures. Dose Osteoarthritis: 60mg once daily. Rheumatoid arthritis: 90mg once daily. Acute gouty arthritis, acute pain and primary dysmenorrhea: 120mg once daily. The 120mg dose used only for the acute symptomatic period, limited to a max of 8 days treatment. Hepatic Insufficiency: Mild (Child-Pugh score 5-6): Max: 60mg once daily. Moderate (Child-Pugh score 7-9): Max: 60mg every other day should not be exceeded. Moderate (Child-Pugh score >9): no clinical or pharmacokinetic data. Renal Insufficiency: not recommended in advanced renal disease (creatinine clearance <30ml/min). No dosage adjustment is necessary in patients with lesser degrees of renal insufficiency (creatinine clearance ≥ 30ml/min) Location Kedai PharmUMMC Administration Taken with or without food. Stability / expiry Store at 30°C (86°F). Protect from moisture and light. Special precautions • Contraindicated in patients with hypersensitivity to any component of this product, congestive Heart Failure (NYHA II-IV), established ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease (including patients who have recently undergone coronary bypass graft surgery or angioplasty), hypertension whose blood pressure has not been adequately controlled and in those who are pregnant. • Risk of thrombotic events may increase with dose and duration of exposure, the shortest duration possible with the lowest effective dose should be used. • Concurrent use with aspirin may increase the risk of GI adverse effects. • Gaution in patients who have previously experienced acute asthmatic attacks, urticaria, or rhinitis, which were precipitated by salicylates or nonselective cyclooxygenase inhibitors. Special notes All to pay full cost. Patient Information May cause hypotension, body pain, dizziness, constipation, agitation, insomnia, GI effects, pruritus and increase sweating. Prepared/checked by Yeap Li Ling / PDS / PL Date compiled/edition 5 June 2009, 1st edition
